70 related articles for article (PubMed ID: 12007184)
1. A three-state mechanism of integrin activation and signal transduction for integrin alpha(v)beta(3).
Gottschalk KE; Günther R; Kessler H
Chembiochem; 2002 May; 3(5):470-3. PubMed ID: 12007184
[No Abstract] [Full Text] [Related]
2. A structural basis for bidirectional integrin signalling.
Filardo EJ; Cheresh DA
Princess Takamatsu Symp; 1994; 24():106-17. PubMed ID: 8983068
[No Abstract] [Full Text] [Related]
3. Structure. An anthropomorphic integrin.
Humphries MJ; Mould AP
Science; 2001 Oct; 294(5541):316-7. PubMed ID: 11598288
[No Abstract] [Full Text] [Related]
4. Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity.
Cini N; Trabocchi A; Menchi G; Bottoncetti A; Raspanti S; Pupi A; Guarna A
Bioorg Med Chem; 2009 Feb; 17(4):1542-9. PubMed ID: 19195898
[TBL] [Abstract][Full Text] [Related]
5. A cell-based adhesion assay for the characterization of integrin alpha v beta 3 antagonists.
Wu JM; Rosser MP; Howlett AR; Feldman RI
Methods Mol Biol; 1999; 129():211-7. PubMed ID: 10494566
[No Abstract] [Full Text] [Related]
6. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand.
Xiong JP; Stehle T; Zhang R; Joachimiak A; Frech M; Goodman SL; Arnaout MA
Science; 2002 Apr; 296(5565):151-5. PubMed ID: 11884718
[TBL] [Abstract][Full Text] [Related]
7. [First atomic view of alpha V beta 3 integrin extracellular domain].
Takagi J
Tanpakushitsu Kakusan Koso; 2002 Feb; 47(2):153-9. PubMed ID: 11840679
[No Abstract] [Full Text] [Related]
8. Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin.
Choi Y; Kim E; Lee Y; Han MH; Kang IC
Proteomics; 2010 Jan; 10(1):72-80. PubMed ID: 19882657
[TBL] [Abstract][Full Text] [Related]
9. Integrin alpha(v)beta(3)-mediated activation of apoptosis.
Brassard DL; Maxwell E; Malkowski M; Nagabhushan TL; Kumar CC; Armstrong L
Exp Cell Res; 1999 Aug; 251(1):33-45. PubMed ID: 10438569
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists.
Keenan RM; Miller WH; Kwon C; Ali FE; Callahan JF; Calvo RR; Hwang SM; Kopple KD; Peishoff CE; Samanen JM; Wong AS; Yuan CK; Huffman WF
J Med Chem; 1997 Jul; 40(15):2289-92. PubMed ID: 9240343
[No Abstract] [Full Text] [Related]
11. Conformations and pharmacophores of cyclic RGD containing peptides which selectively bind integrin alpha(v)beta3.
Locardi E; Mullen DG; Mattern RH; Goodman M
J Pept Sci; 1999 Nov; 5(11):491-506. PubMed ID: 10587313
[TBL] [Abstract][Full Text] [Related]
12. Role of integrin alpha(v)beta3 in vascular biology.
Byzova TV; Rabbani R; D'Souza SE; Plow EF
Thromb Haemost; 1998 Nov; 80(5):726-34. PubMed ID: 9843163
[No Abstract] [Full Text] [Related]
13. Potent integrin antagonists from a small library of RGD-including cyclic pseudopeptides.
Belvisi L; Bernardi A; Checchia A; Manzoni L; Potenza D; Scolastico C; Castorina M; Cupelli A; Giannini G; Carminati P; Pisano C
Org Lett; 2001 Apr; 3(7):1001-4. PubMed ID: 11277780
[TBL] [Abstract][Full Text] [Related]
14. The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3.
Ludbrook SB; Barry ST; Delves CJ; Horgan CM
Biochem J; 2003 Jan; 369(Pt 2):311-8. PubMed ID: 12358597
[TBL] [Abstract][Full Text] [Related]
15. Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein.
Byzova TV; Kim W; Midura RJ; Plow EF
Exp Cell Res; 2000 Feb; 254(2):299-308. PubMed ID: 10640428
[TBL] [Abstract][Full Text] [Related]
16. Effect of ligand conformation on melanoma cell alpha3beta1 integrin-mediated signal transduction events: implications for a collagen structural modulation mechanism of tumor cell invasion.
Lauer JL; Gendron CM; Fields GB
Biochemistry; 1998 Apr; 37(15):5279-87. PubMed ID: 9548759
[TBL] [Abstract][Full Text] [Related]
17. Role of vitronectin and its receptors in haemostasis and vascular remodeling.
Preissner KT; Seiffert D
Thromb Res; 1998 Jan; 89(1):1-21. PubMed ID: 9610756
[No Abstract] [Full Text] [Related]
18. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
[TBL] [Abstract][Full Text] [Related]
19. Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior.
Del Gatto A; Zaccaro L; Grieco P; Novellino E; Zannetti A; Del Vecchio S; Iommelli F; Salvatore M; Pedone C; Saviano M
J Med Chem; 2006 Jun; 49(11):3416-20. PubMed ID: 16722662
[TBL] [Abstract][Full Text] [Related]
20. Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model.
Luna J; Tobe T; Mousa SA; Reilly TM; Campochiaro PA
Lab Invest; 1996 Oct; 75(4):563-73. PubMed ID: 8874387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
